TALARIS THERAPEUTICS, INC.

Profile

Company Names

TALARIS THERAPEUTICS, INC.

Addresses

201 E. JEFFERSON ST., SUITE 110B, LOUISVILLE, KY 40202

Phone Numbers

502-569-1059

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$114,999,989.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2020-09-22 
$114,999,989.00 
$114,999,989.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SANDIP 
 
AGARWALA 
DIRECTOR
CYDAN II, INC.   |  TIBURIO THERAPEUTICS INC.   |  TALARIS THERAPEUTICS, INC.
NICK 
 
GALAKATOS 
DIRECTOR
AEROVANCE INC   |  LINK MEDICINE CORP   |  BLACKSTONE LIFE SCIENCES V L.P.   |  BLACKSTONE LIFE SCIENCES V (LUX) SCSP   |  TALARIS THERAPEUTICS, INC.
SUZANNE 
 
ILDSTAD 
EXECUTIVE OFFICER, DIRECTOR
TALARIS THERAPEUTICS, INC.
GEOFF 
 
MACKAY 
DIRECTOR
EGENESIS, INC.   |  REPLICEL LIFE SCIENCES INC.   |  GEMSTONE BIOTHERAPEUTICS, LLC   |  REDACTBIO, INC.   |  TALARIS THERAPEUTICS, INC.   |  SATELLOS BIOSCIENCE INC.
MARK 
 
MCDADE 
DIRECTOR
FIVE PRIME THERAPEUTICS INC   |  DERMIRA, INC.   |  PLATELET BIOGENESIS, INC.   |  AMPHIVENA THERAPEUTICS, INC.   |  ICOSAVAX, INC.   |  TALARIS THERAPEUTICS, INC.   |  WINDMIL THERAPEUTICS, INC.   |  BOULDER CARE, INC.   |  SODA HEALTH, INC.   |  DUALITAS THERAPEUTICS, INC.
FRANCOIS 
 
NADER 
DIRECTOR
CLEMENTIA PHARMACEUTICALS INC.   |  TALARIS THERAPEUTICS, INC.   |  BENEVOLENTAI   |  GEN1E LIFESCIENCES INC.
SCOTT 
 
REQUADT 
EXECUTIVE OFFICER, DIRECTOR
TYRX PHARMA INC   |  TYRX, INC.   |  CLARUS DEFINED EXIT I, L.P.   |  CLARUS DE II, L.P.   |  ESSA PHARMA INC.   |  AVROBIO, INC.   |  VBI VACCINES INC/BC   |  CLARUS IV-D, L.P.   |  CLARUS IV-C, L.P.   |  CLARUS IV-B, L.P.   |  CLARUS IV-A, L.P.   |  TALARIS THERAPEUTICS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-10-07
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-09-22 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#